Correlation Between Quoin Pharmaceuticals and GT Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and GT Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and GT Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and GT Biopharma, you can compare the effects of market volatilities on Quoin Pharmaceuticals and GT Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of GT Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and GT Biopharma.

Diversification Opportunities for Quoin Pharmaceuticals and GT Biopharma

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Quoin and GTBP is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and GT Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GT Biopharma and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with GT Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GT Biopharma has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and GT Biopharma go up and down completely randomly.

Pair Corralation between Quoin Pharmaceuticals and GT Biopharma

Given the investment horizon of 90 days Quoin Pharmaceuticals Ltd is expected to under-perform the GT Biopharma. In addition to that, Quoin Pharmaceuticals is 1.42 times more volatile than GT Biopharma. It trades about -0.35 of its total potential returns per unit of risk. GT Biopharma is currently generating about -0.25 per unit of volatility. If you would invest  294.00  in GT Biopharma on November 3, 2024 and sell it today you would lose (88.00) from holding GT Biopharma or give up 29.93% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Quoin Pharmaceuticals Ltd  vs.  GT Biopharma

 Performance 
       Timeline  
Quoin Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Quoin Pharmaceuticals Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
GT Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GT Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's fundamental drivers remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Quoin Pharmaceuticals and GT Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Quoin Pharmaceuticals and GT Biopharma

The main advantage of trading using opposite Quoin Pharmaceuticals and GT Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, GT Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GT Biopharma will offset losses from the drop in GT Biopharma's long position.
The idea behind Quoin Pharmaceuticals Ltd and GT Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities